ImmuPharma PLC (LON:IMM)

ImmuPharma PLC (LON:IMM)


Share Price
12.25 p
Change
-0.75 (-5.77 %)
Market Cap
£17.08 m
Proactive Investors - Run By Investors For Investors

ImmuPharma PLC

ImmuPharma PLC is a pharmaceutical development company focusing on developing novel medicines in specialist markets with serious unmet need. Lupuzor™ is the company’s most advanced drug in development and is a treatment for lupus, a life threatening autoimmune disease and has now completed dosing Lupus patients in its Phase III pivotal trial. This is only part of our story as our scientists...

EPIC: IMM
Market: AIM:IMM
52-week High/Low: 193.00p / 9.06p
Sector: Pharma & Biotech
Market Cap: 17.08M
Website: www.immupharma.co.uk
col 3
col 4
col 5
col 6

Big picture - Why invest in ImmuPharma PLC


ImmuPharma PLC Timeline

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use